The application of NMES in critically ill patients is attractive because specifically, in the early phase, selective type II atrophy and an up-regulation of “atrophy genes” in type IIA fibers were observed [21]. Interestingly
The application of NMES in critically ill patients is attractive becausespecifically, in the early phase, selective type II atrophy and anup-regulation of “atrophy genes” in type IIA fibers were observed [21].Interestingly